Researchers found that Halicin, an AI-identified drug, effectively inhibited most multidrug-resistant bacteria except ...

While a handful of states have banned the sale or production of lab-grown meat within their borders, the infant industry is still innovating. Cultivated salmon company Wildtype received approval ...

While a handful of states have banned the sale or production of lab-grown meat within their borders, the infant industry is still innovating. Cultivated salmon company Wildtype received approval ...

Land ho! You’ve heard of fresh-caught salmon and even farm-raised — but what about lab-grown? San Francisco cellular agriculture company Wildtype is the latest company to get FDA approval for ...

The FDA has opted to not appeal a federal court decision that struck down the agency’s rule to regulate laboratory-developed tests as medical devices. The 60-day window for appeal has passed ...

ZL-1310 also has an FDA orphan drug status for small cell lung cancer treatment. Zai Lab is on track to initiate a pivotal study for ZL-1310 in small cell lung cancer in 2025, the company said.

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our milk is still safe to consume. Here's what you need to know.

A U.S. district judge foiled the Food and Drug Administration's plan put forth under the Biden administration to regulate lab-developed tests like medical devices.

A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...

A key lab that oversees US pharmaceutical safety is in limbo following moves by the Department of Government Efficiency, raising questions about the fate of the lab and the new administration’s ...

Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) January 22, 2025 11:15 PM Eastern Standard Time ...

On April 29, 2024, the Food and Drug Administration (FDA) announced a final rule to consider laboratory-developed tests (LDTs) to be medical devices and thus under FDA oversight. 1 LDTs are ...